Skip to Content

FDA approves AI-based at-home sleep test

FDA approves AI-based at-home sleep test

NAMUR, Belgium – Sunrise has received U.S. Food and Drug Administration (FDA) clearance for its second generation at-home sleep apnea test that uses artificial intelligence (AI) to diagnose obstructive sleep apnea and sleep-related breathing disorders. The technology captures Mandibular Jaw Movements (MJM) with one point of contact - a lightweight sensor placed on the chin that records the jaw’s movements. Data is collected through an app, analyzed with an algorithm using AI and made available to health care providers through a secure online portal. “We have clinically validated our sensor against the gold standard of polysomnography on thousands of patients to measure sleep-disordered breathing,” said Laurent Martinot, CEO and co-founder of Sunrise. New features on the at-home sleep apnea test include the ability for patients to complete multi-night testing.

Comments

To comment on this post, please log in to your account or set up an account now.